Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC AST5902 trimesylate | 2929417-90-1 | 98.75% | 842.88 | 100 MG
SDP

Catalog No. 5000352462
Encompass_Preferred

AST5902 trimesylate is the principal metabolite of Alflutinib in vitro and in vivo. It exhibits antineoplastic activity, and Alflutinib is known as an EGFR inhibitor.

  • Principal metabolite of Alflutinib
  • Exhibits antineoplastic activity
  • Targets EGFR

Catalog No. 50-003-52462 Supplier Medchemexpress LLC Supplier No. HY138627A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AST5902 trimesylate is the principal metabolite of Alflutinib in vitro and in vivo. It exhibits antineoplastic activity, and Alflutinib is known as an EGFR inhibitor.

  • Principal metabolite of Alflutinib
  • Exhibits antineoplastic activity
  • Targets EGFR

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.